{"entity":{"type":"insider","cik":"0001271123","url":"/insider/0001271123","json_url":"/insider/0001271123.json","name":"LUCI DAVID P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":10,"first":"2003-11-25","last":"2025-01-08","span_basis":"filed_date"},"name_variants":[{"name":"LUCI DAVID P","source":"filing","n_filings":10,"first_seen":"2003-11-25","last_seen":"2025-01-08"}],"transactions":[{"id":4986135,"accession":"0001104659-25-002052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-002052","line_url":"/filing/0001104659-25-002052#line-1","is_derivative":false,"issuer_cik":"0001271123","issuer_name":"Acurx Pharmaceuticals, Inc.","issuer_ticker":"ACXP","issuer_name_source":null,"issuer_url":"/issuer/0001271123","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":49261.0,"shares_display":"49,261","price_per_share":1.015,"price_display":"1.02","price_state":"stated","total_value":49999.915,"total_display":"49,999.92","total_whole":"50,000","shares_owned_after":1097458.0,"shares_owned_after_display":"1,097,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-08","scope":"insider"},{"id":6990919,"accession":"0001104659-22-084315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-084315","line_url":"/filing/0001104659-22-084315#line-1","is_derivative":false,"issuer_cik":"0001271123","issuer_name":"Acurx Pharmaceuticals, Inc.","issuer_ticker":"ACXP","issuer_name_source":null,"issuer_url":"/issuer/0001271123","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":19737.0,"shares_display":"19,737","price_per_share":3.8,"price_display":"3.80","price_state":"stated","total_value":75000.6,"total_display":"75,000.60","total_whole":"75,001","shares_owned_after":1028460.0,"shares_owned_after_display":"1,028,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-27","filed_date":"2022-07-29","scope":"insider"},{"id":4721023,"accession":"0001104659-21-142471","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-142471","line_url":"/filing/0001104659-21-142471#line-1","is_derivative":false,"issuer_cik":"0001271123","issuer_name":"Acurx Pharmaceuticals, Inc.","issuer_ticker":"ACXP","issuer_name_source":null,"issuer_url":"/issuer/0001271123","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Director, Officer (President and CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5200.0,"shares_display":"5,200","price_per_share":4.8,"price_display":"4.80","price_state":"stated","total_value":24960.0,"total_display":"24,960.00","total_whole":"24,960","shares_owned_after":1008723.0,"shares_owned_after_display":"1,008,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-22","scope":"insider"},{"id":6518064,"accession":"0001104659-14-020867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-14-020867","line_url":"/filing/0001104659-14-020867#line-1","is_derivative":false,"issuer_cik":"0001271123","issuer_name":"Dipexium Pharmaceuticals, Inc.","issuer_ticker":"DPRX","issuer_name_source":null,"issuer_url":"/issuer/0001271123","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Director, Officer (President, CEO, Secretary), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, CEO, Secretary","security_title":"Common Stock, par value $.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2083.0,"shares_display":"2,083","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":24996.0,"total_display":"24,996.00","total_whole":"24,996","shares_owned_after":1829447.0,"shares_owned_after_display":"1,829,447","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2014-03-19","scope":"insider"},{"id":2642324,"accession":"0000743884-08-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000743884-08-000002","line_url":"/filing/0000743884-08-000002#line-1","is_derivative":false,"issuer_cik":"0000743884","issuer_name":"MACROCHEM CORP","issuer_ticker":"MACM.OB","issuer_name_source":null,"issuer_url":"/issuer/0000743884","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer (Vice President)","role_mark":"O","role_mark_label":"Officer (Vice President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Vice President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":1770.0,"total_display":"1,770.00","total_whole":"1,770","shares_owned_after":44667.0,"shares_owned_after_display":"44,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-12-31","filed_date":"2008-01-04","scope":"insider"},{"id":4146945,"accession":"0001116679-06-000624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001116679-06-000624","line_url":"/filing/0001116679-06-000624#line-1","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"AMEXBIV","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer (CFO & Gen. Counsel)","role_mark":"O","role_mark_label":"Officer (CFO & Gen. Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Gen. Counsel","security_title":"Common Stock, par value $.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":135000.0,"shares_display":"135,000","price_per_share":7.9605,"price_display":"7.96","price_state":"stated","total_value":1074667.5,"total_display":"1,074,667.50","total_whole":"1,074,668","shares_owned_after":169054.0,"shares_owned_after_display":"169,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-03-06","filed_date":"2006-03-07","scope":"insider"},{"id":4146932,"accession":"0001116679-06-000587","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001116679-06-000587","line_url":"/filing/0001116679-06-000587#line-1","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"AMEXBIV","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer (CFO & Gen. Counsel)","role_mark":"O","role_mark_label":"Officer (CFO & Gen. Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & Gen. Counsel","security_title":"Common Stock, par value $.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":8.5717,"price_display":"8.57","price_state":"stated","total_value":557160.5,"total_display":"557,160.50","total_whole":"557,161","shares_owned_after":304054.0,"shares_owned_after_display":"304,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2006-02-28","filed_date":"2006-03-02","scope":"insider"},{"id":1667915,"accession":"0001116679-05-002120","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001116679-05-002120","line_url":"/filing/0001116679-05-002120#line-5","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer (CFO, General Counsel)","role_mark":"O","role_mark_label":"Officer (CFO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, General Counsel","security_title":"Common Stock, par value $.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":28000.0,"total_display":"28,000.00","total_whole":"28,000","shares_owned_after":369054.0,"shares_owned_after_display":"369,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-03-23","filed_date":"2005-08-12","scope":"insider"},{"id":1667913,"accession":"0001116679-05-002120","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001116679-05-002120","line_url":"/filing/0001116679-05-002120#line-3","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer (CFO, General Counsel)","role_mark":"O","role_mark_label":"Officer (CFO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, General Counsel","security_title":"Common Stock, par value $.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23946.0,"shares_display":"23,946","price_per_share":8.81,"price_display":"8.81","price_state":"stated","total_value":210964.26,"total_display":"210,964.26","total_whole":"210,964","shares_owned_after":369054.0,"shares_owned_after_display":"369,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-01-03","filed_date":"2005-08-12","scope":"insider"},{"id":1667912,"accession":"0001116679-05-002120","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-05-002120","line_url":"/filing/0001116679-05-002120#line-2","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"BIVN","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer (CFO, General Counsel)","role_mark":"O","role_mark_label":"Officer (CFO, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO, General Counsel","security_title":"Common Stock, par value $.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":369054.0,"shares_owned_after_display":"369,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-12-30","filed_date":"2005-08-12","scope":"insider"},{"id":524863,"accession":"0001116679-04-001455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001116679-04-001455","line_url":"/filing/0001116679-04-001455#line-1","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"AMEXBIV","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Exhibit 99.1","security_title":"Common Stock, par value $.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.25,"price_display":"8.25","price_state":"stated","total_value":8250.0,"total_display":"8,250.00","total_whole":"8,250","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-06-22","filed_date":"2004-06-24","scope":"insider"},{"id":52424,"accession":"0001116679-03-002528","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001116679-03-002528","line_url":"/filing/0001116679-03-002528","is_derivative":false,"issuer_cik":"0001028205","issuer_name":"BIOENVISION INC","issuer_ticker":"AMEXBIV","issuer_name_source":null,"issuer_url":"/issuer/0001028205","owner_cik":"0001271123","owner_name":"LUCI DAVID P","owner_display_name":"LUCI DAVID P","owner_url":"/insider/0001271123","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Exhibit 99.1","security_title":"Common Stock, par value $.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":3.3971428571428572,"price_display":"3.40","price_state":"stated","total_value":23780.0,"total_display":"23,780.00","total_whole":"23,780","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2003-11-19","filed_date":"2003-11-25","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001736243","name":"Acurx Pharmaceuticals, Inc.","url":"/issuer/0001736243","role":"Director, Officer (President and CEO), Ten percent owner","n_filings":3,"first_seen":"2021-11-22","last_seen":"2025-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001497504","name":"Dipexium Pharmaceuticals, Inc.","url":"/issuer/0001497504","role":"Director, Officer (President, CEO, Secretary), Ten percent owner","n_filings":1,"first_seen":"2014-03-19","last_seen":"2014-03-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000743884","name":"MACROCHEM CORP","url":"/issuer/0000743884","role":"Officer (Vice President)","n_filings":1,"first_seen":"2008-01-04","last_seen":"2008-01-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001028205","name":"BIOENVISION INC","url":"/issuer/0001028205","role":"Officer (CFO & Gen. Counsel)","n_filings":5,"first_seen":"2003-11-25","last_seen":"2006-03-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001271123","retrieved_at":"2026-08-23T04:14:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}